Bernstein Bruce 4

What Happened

• Bruce Bernstein, a director of Petros Pharmaceuticals, was granted 1,875,000 restricted shares on 2026-06-05. The award was recorded at $0.00 per share (no cash paid at grant).
• Under the grant, 50% of the shares vested on the grant date and the remaining 50% will vest on the six‑month anniversary, contingent on continued service (see footnote F1).

Key Details

• Transaction date: 2026-06-05
• Transaction type/code: Award/Grant (A)
• Shares granted: 1,875,000 shares
• Price: $0.00 per share (acquired)
• Vesting: 50% vested at grant; remaining 50% vests six months after grant if service continues (Footnote F1)
• Shares owned after transaction: Not disclosed in the provided filing
• Filing/report date: Period of report and filing date 2026-06-05 (timely)

Context

• These are restricted stock awards, which are typically subject to vesting and transfer restrictions until vested; they are not an immediate open‑market purchase or sale.
• Awards are common forms of executive/director compensation and don’t, by themselves, signal the insider’s intent to buy or sell stock.